{"slideshow_credits": null, "snippet": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "abstract": "Increasing number of hemophilia drug makers and specialty pharmacies are employing patients and their relatives to gain sales advantage and increase revenue; ethical issues are raised. ", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2016/01/14/business/hemophilia-patient-or-drug-seller-dual-role-creates-ethical-quandary.html", "lead_paragraph": "When hemophiliacs make their living by selling lucrative hemophilia drugs, patient advocates say it creates a dangerous conflict of interest.", "headline": {"main": "Hemophilia Patient or Drug Seller? Dual Role Creates Ethical Quandary", "print_headline": "The Patient&#8217;s Sales Pitch "}, "_id": "569694b938f0d865e6c34836", "word_count": "1254", "multimedia": [{"height": 126, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 398, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "398"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/14/business/14hemophilia-web1/14hemophilia-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-01-14T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Hemophilia", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Novo Nordisk A/S", "is_major": "N", "rank": "11"}, {"name": "organizations", "value": "Baxalta Inc.", "is_major": "N", "rank": "12"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Conflicts of Interest", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Blood", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Ethics and Official Misconduct", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Hemophilia of North Carolina", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "National Hemophilia Foundation", "is_major": "N", "rank": "7"}, {"name": "organizations", "value": "MedfusionRx LLC", "is_major": "N", "rank": "8"}, {"name": "organizations", "value": "Bayer AG", "is_major": "N", "rank": "9"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "N", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "News"}